49 related articles for article (PubMed ID: 9260971)
1. Identification of the Biosynthetic Pathway for the Antibiotic Bicyclomycin.
Patteson JB; Cai W; Johnson RA; Santa Maria KC; Li B
Biochemistry; 2018 Jan; 57(1):61-65. PubMed ID: 29053243
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide relationship between R-loop formation and antisense transcription in Escherichia coli.
Raghunathan N; Kapshikar RM; Leela JK; Mallikarjun J; Bouloc P; Gowrishankar J
Nucleic Acids Res; 2018 Apr; 46(7):3400-3411. PubMed ID: 29474582
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting.
Wharfe ES; Winder CL; Jarvis RM; Goodacre R
Appl Environ Microbiol; 2010 Apr; 76(7):2075-85. PubMed ID: 20118361
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structure of transcription termination factor Rho from Mycobacterium tuberculosis reveals bicyclomycin resistance mechanism.
Saridakis E; Vishwakarma R; Lai-Kee-Him J; Martin K; Simon I; Cohen-Gonsaud M; Coste F; Bron P; Margeat E; Boudvillain M
Commun Biol; 2022 Feb; 5(1):120. PubMed ID: 35140348
[TBL] [Abstract][Full Text] [Related]
5. Mastering the control of the Rho transcription factor for biotechnological applications.
Villa TG; Abril AG; Sánchez-Pérez A
Appl Microbiol Biotechnol; 2021 May; 105(10):4053-4071. PubMed ID: 33963893
[TBL] [Abstract][Full Text] [Related]
6. Study of bicyclomycin biosynthesis in Streptomyces cinnamoneus by genetic and biochemical approaches.
Witwinowski J; Moutiez M; Coupet M; Correia I; Belin P; Ruzzini A; Saulnier C; Caraty L; Favry E; Seguin J; Lautru S; Lequin O; Gondry M; Pernodet JL; Darbon E
Sci Rep; 2019 Dec; 9(1):20226. PubMed ID: 31882990
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Rho Activity Increases Expression of SaeRS-Dependent Virulence Factor Genes in Staphylococcus aureus, Showing a Link between Transcription Termination, Antibiotic Action, and Virulence.
Nagel A; Michalik S; Debarbouille M; Hertlein T; Gesell Salazar M; Rath H; Msadek T; Ohlsen K; van Dijl JM; Völker U; Mäder U
mBio; 2018 Sep; 9(5):. PubMed ID: 30228237
[No Abstract] [Full Text] [Related]
8. Depleting Mycobacterium tuberculosis of the transcription termination factor Rho causes pervasive transcription and rapid death.
Botella L; Vaubourgeix J; Livny J; Schnappinger D
Nat Commun; 2017 Mar; 8():14731. PubMed ID: 28348398
[TBL] [Abstract][Full Text] [Related]
9. Bacterial Transcription as a Target for Antibacterial Drug Development.
Ma C; Yang X; Lewis PJ
Microbiol Mol Biol Rev; 2016 Mar; 80(1):139-60. PubMed ID: 26764017
[TBL] [Abstract][Full Text] [Related]
10. ATP-dependent motor activity of the transcription termination factor Rho from Mycobacterium tuberculosis.
D'Heygère F; Schwartz A; Coste F; Castaing B; Boudvillain M
Nucleic Acids Res; 2015 Jul; 43(12):6099-111. PubMed ID: 25999346
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the primary sigma factor σA and termination factor rho that reduce susceptibility to cell wall antibiotics.
Lee YH; Helmann JD
J Bacteriol; 2014 Nov; 196(21):3700-11. PubMed ID: 25112476
[TBL] [Abstract][Full Text] [Related]
12. Prediction of transcriptional terminators in Bacillus subtilis and related species.
de Hoon MJ; Makita Y; Nakai K; Miyano S
PLoS Comput Biol; 2005 Aug; 1(3):e25. PubMed ID: 16110342
[TBL] [Abstract][Full Text] [Related]
13. The transcription termination factor Rho is essential and autoregulated in Caulobacter crescentus.
Italiani VC; Marques MV
J Bacteriol; 2005 Jun; 187(12):4290-4. PubMed ID: 15937192
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Bacillus subtilis trpEDCFBA operon is influenced by translational coupling and Rho termination factor.
Yakhnin H; Babiarz JE; Yakhnin AV; Babitzke P
J Bacteriol; 2001 Oct; 183(20):5918-26. PubMed ID: 11566991
[TBL] [Abstract][Full Text] [Related]
15. rho is not essential for viability or virulence in Staphylococcus aureus.
Washburn RS; Marra A; Bryant AP; Rosenberg M; Gentry DR
Antimicrob Agents Chemother; 2001 Apr; 45(4):1099-103. PubMed ID: 11257021
[TBL] [Abstract][Full Text] [Related]
16. Effects of bicyclomycin on RNA- and ATP-binding activities of transcription termination factor Rho.
Carrano L; Bucci C; De Pascalis R; Lavitola A; Manna F; Corti E; Bruni CB; Alifano P
Antimicrob Agents Chemother; 1998 Mar; 42(3):571-8. PubMed ID: 9517934
[TBL] [Abstract][Full Text] [Related]
17. Transcription termination factor Rho is essential for Micrococcus luteus.
Nowatzke WL; Keller E; Koch G; Richardson JP
J Bacteriol; 1997 Aug; 179(16):5238-40. PubMed ID: 9260971
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis for the mode of action of bicyclomycin.
Kohn H; Widger W
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an unusual Rho factor from the high G + C gram-positive bacterium Micrococcus luteus.
Nowatzke WL; Richardson JP
J Biol Chem; 1996 Jan; 271(2):742-7. PubMed ID: 8557681
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
